Background The 4.5% hypertonic saline (HS) challenge test has
Results Forty-five subjects, consisting of 22 boys and 23 girls, were enrolled. The average age of subjects was 9 years old. Atopic history in the family or in subjects themselves was found in 80% of subjects. Eight subjects had FEV 1 of <80%. Forty-four subjects were diagnosed with asthma based on a baseline FEV 1 of <80% or a positive histamine provocation test. Thirty-seven subjects had a positive 4.5% HS challenge test; all had asthma. Sensitivity and specificity of the 4.5% HS challenge test were 84.1% and 100.0%, respectively; the positive and negative predictive values were 100.0% and 12.5%, respectively. The positive likelihood ratio was infinite and negative likelihood ratio was 0.16.
Conclusion
The 4.5% hypertonic saline challenge test can be used as an alternative bronchial provocation test in diagnosing asthma in children with CRC. Further study with larger sample size is needed for widespread usage. Keywords: 4.5% hypertonic saline challenge test, bronchial provocation test, asthma, chronic recurrent cough F or the last 15 years, 4.5% hypertonic saline (4.5% HS) has been used for bronchial challenge tests in many countries. [1] [2] [3] [4] [5] [6] This substance is inexpensive, easily formulated, and can be made in a simple medical laboratory. 2, 7 Previous studies showed that 4.5% HS challenge test had a specificity of 92-100% and a sensitivity of 47-67% when used to diagnose asthma. 3, 4, 6 Currently, histamine and metacholine are gold standard substances for bronchial challenge tests. However, histamine is difficult to obtain in Indonesia because it is expensive and must be imported. [7] [8] [9] The sensitivity and specificity of histamine challenge test have been reported to be 92-100% and 92-93%, respectively. 4, 10, 11 It has been suggested that 4.5% HS challenge test is a more specific method for diagnosing asthma because its basic mechanism involves initial inflammation followed by contraction of bronchial smooth muscle cells, 2,12,13 whereas histamine attaches immediately to bronchial smooth muscle receptors. 1, [14] [15] [16] Furthermore, 4.5% HS is a more natural, nonpharmacologic substance, making it preferable to and possibly safer than histamine. 2 The prevalence of asthma in children with chronic recurrent cough (CRC) is quite high; approximately 40 to 60%. [17] [18] [19] [20] The purpose of bronchial provocation testing on CRC patients is to reconfirm the diagnosis of asthma rather than to screen the patients, since most CRC patients who came to the hospital had already been treated before. Therefore, we need a challenge test which can establish the diagnosis of asthma in these patients. This study aimed to determine the accuracy of 4.5% HS challenge test in diagnosing asthma in children with CRC.
Methods
We reviewed children aged 6 to 14 years with CRC who visited the outpatient clinic of the Department of Child Health, Cipto Mangunkusumo Hospital, Jakarta. The study was conducted from October 2003 to March 2004. We included children suffering from CRC who were cooperative and had been drug-free for 3 days before the examination. Children were excluded if they were having asthma attacks (baseline value of FEV 1 <65%), were unable to perform lung function tests, had FEV 1 differing for more than 5-10% in two subsequent measurements, were clinically suspected of cardiovascular disorders/anomalies, or had pulmonary congenital anomaly, chronic pulmonary disease, gastroesophageal reflux, or focal lesions in the lungs. Chronic recurrent cough was defined as cough persisting for more than 3 weeks or recurring more than 3 times in 3 consecutive months. Subjects were recruited on a voluntary basis. Written informed consent was obtained from the subjects' parents. The study protocol had been approved by the Medical Research Ethics Committee of the Medical School, University of Indonesia.
On the first visit, lung function tests were conducted to determine the baseline value of FEV 1 . If FEV 1 was <80%, subjects were provoked with 4.5% HS only. If FEV 1 was =80%, histamine provocation test was performed, followed by 4.5% HS challenge test one to two weeks later. Lung function tests and provocation tests were performed by the same examiner.
The 4.5% HS provocation test was conducted according to the method set by Riedler. 5 Provocation time was increased gradually from 0.5 minutes to 1, 2, 4, and 8 minutes. The cut-off point for a positive provocation test was 8 minutes. 5 The 4.5% HS challenge test was considered positive if FEV 1 decreased 15% from the baseline (PD 15 ) after the dose had been given for up to 8 minutes. The test was considered negative if after 8 minutes of provocation FEV 1 decreased <15% from the baseline. Histamine provocation test was conducted based on the Cockroft method. 10 Histamine was given with increasing concentrations, starting from 0.125 and increased to 0.25, 0.5, 1, 2, 4, up to 8 mg/dl. The cutoff point for a positive test was 8 mg/dl. The test was considered positive if FEV 1 decreased 15% from the baseline (PC 15 ) at a concentration of up to 8 mg/dl and negative if the decrease in FEV 1 was <15% at a concentration of >8mg/dl. The FEV 1 measurement was repeated each time the dosage or provocation time of histamine or 4.5% HS was increased. Provocation was stopped when FEV 1 dropped below 15% of the baseline value. When this happened, the patient was given a β2-agonist. After β2-agonist inhalation, FEV 1 measurement was repeated. The subject was released when FEV 1 had returned to normal.
The results of hypertonic saline challenge test were compared to the presence or absence of asthma according to baseline FEV 1 value (if baseline FEV 1 was <80%) or histamine provocation test (if baseline FEV 1 was 80%). The sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios of the 4.5% HS challenge test were calculated using a 2x2 table. Data were processed using SPSS 11.0 for Windows.
Results
Forty-five subjects were enrolled in the study, consisting of 22 boys and 23 girls. The subjects' age ranged from 6 to 14 years, with an average of 9 years. Thirty-seven subjects (82%) had baseline FEV 1 of ≥80% ( Table 1) . FEV 1 varied from 67.4% to 137% with an average of 93.2%. Eight subjects were not provoked with histamine because baseline value of FEV 1 was <80%. Fifty-one percent of subjects had atopic history themselves and 76% had atopic history in the family. In 80% of subjects, atopic history was found both in the family and in subjects themselves.
Based on operational terms, 44 subjects had asthma, comprising of 8 patients with FEV 1 of <80% and 36 patients with positive histamine provocation test. Some had accompanying diseases such as sinusitis and pulmonary tuberculosis ( Table 2) .
Out of 37 subjects on whom the histamine provocation test was conducted, 36 were positive and 1 was negative. Twenty-nine subjects (81%) had PC 15 of <0.5 mg/ml, 4 (11%) had PC 15 of 0.5-2 mg/ml, and 3 (8%) had PC 15 of 2-8 mg/ml. The 2x2 table constructed from the test results is shown in Table 3 . Based on these results, the sensitivity and specificity of the 4.5% HS challenge test were 84% and 100%, respectively. For the prevalence obtained among our subjects, the positive and negative predictive values were 100% and 13%, respectively. The positive likelihood ratio was infinite and the negative likelihood ratio was 0.16.
Discussion
The ratio between male and female children with CRC was nearly equal, while the prevalence of asthma in pre-pubertal males tends to be higher than in females. In this study, the ratio between males and females were close to equal (1:1.1), with the number of females slightly higher than males. This outcome was compatible with a study by Wright, which reported that CRC was equally prevalent in males as in females. 17, 21 The mean age of subjects was 9 years old (range 6 to 14 years). In our study, subjects aged 6 to 12 years (93%) largely outnumbered those aged 13 to 14 years (7%). This finding showed that the closer a subject gets to puberty, the less CRC and asthma occur, in line with the increase of FEV 1 which reaches its peak at the age of 14 years. 22 Wright also stated that CRC prevalence increases until the age of 6 years and decreases at the age of 11 years. 17 The majority of subjects in this study (78%) had a baseline FEV 1 value of ³80%. Baseline FEV 1 above 80% indicates good lung function, and in asthmatic patients it is considered as infrequent episodic asthma. Most of the subjects (80%) had atopic history in the family and/or in themselves. This result highlights the importance of atopic history in asthma. A study by Clough found that the presence of atopic history was closely related to low FEV 1 values, increased bronchial hyperresponsiveness, FEV 1 variability, and severity of respiratory symptoms. 23 Forty-four (98%) patients with CRC in this study were diagnosed with asthma. This proportion was higher than that obtained by studies of Gunadi 19 and Rahajoe, 20 which found the asthma prevalence among CRC patients ranging between 62.5% and 64.5%. In both studies, the diagnosis of asthma was based on clinical examination only, which may account for this difference.
The prevalence of sinusitis in asthmatic children was quite high. Several theories have attempted to clarify this occurrence. One postulated that the bronchus becomes more reactive due to the existence of postnasal drip or due to the effect of inflammatory mediator stimulation reaching the nasal passageway, causing the bronchus to tighten. Erwin et al 24 found that obstruction of the upper nassal passageway occurred when sinusitis was left untreated. After medication, obstruction of the upper nasal passageways will disappear. In this study, it turned out that 20 (63%) of 32 asthma patients had sinusitis based on sinus X-ray. This prevalence was possibly higher if the sinus photo was taken for all patients.
We found the sensitivity and specificity of the 4.5% HS challenge test to be 84.8% and 100%, respectively. This is in accordance with results found in previous studies; the specificity of the test has always been found to be higher than the sensitivity. Araki 4 found that the test's specificity was 100%, while its sensitivity was 58%. The lower sensitivity value in Araki's study was due to the use of control subjects, which resulted in less positive test results. Moreover, the majority of subjects in Araki's study were mildly asthmatic patients with FEV 1 values only slightly below 80%. 4 In our study, there were 8 patients with FEV 1 values below 70%, with a range of 67.4 to 79.8%.
In both Araki's and our study the specificity was 100%. All control subjects in Araki's study had a negative result. 4 In our study, patients with CRC who had negative results in both the histamine provocation test and 4.5% HS challenge test were finally diagnosed with lung tuberculosis and sinusitis. Another study by Supriyatno 7 found the sensitivity and specificity of 4.5% HS challenge test to be 86.7% and 85.7%, respectively.
Epidemiological studies to evaluate the reliability of the 4.5% HS challenge test in diagnosing asthma had been carried out by Riedler 5 and Liz. 6 Both studies were conducted in children of 13 to 15 years old with wheezing in the past 12 months and compared them with control subjects. Riedler's study reported sensitivity and specificity values of 47% and 92%, respectively, while Liz's reported these to be 44% and 90%, respectively. 5, 6 Liz also found that when the test was performed on subjects who had been clinically diagnosed with asthma by doctors, the sensitivity increased to 67%, while the specificity remained constant. 6 The higher specificity of the 4.5% HS challenge test when compared to sensitivity may be caused by the work mechanism of the 4.5% HS solution, which activates inflammatory mediators first and creates bronchial contractions later. This is in line with the basis of asthma patophysiology, which is inflammation. 12, 13 In normal subjects inflammation does not occur, thus producing a negative challenge test. A study by Smith concluded that, being a more specific than sensitive test, the 4.5% HS provocation test may result in a high number of false negatives. 25 In our study, out of 44 patients with positive histamine provocation test, 7 had negative 4.5% HS challenge test. Five out of seven patients with histamine PC 15 values of 0.25 to 2 mg/dl (bronchial hyperresponsiveness) had atopic history in the family; some had a history of wheezing. These five patients were clinically categorized as having mild asthma, with asthma attacks occuring less than once a month and FEV 1 of >80%. This was in accordance with findings by Smith, which showed that patients with mild asthma may have negative 4.5% HS challenge test results. 25 Of the subjects with histamine PC 15 close to the cut-off point of 8 mg/ dl, 2 were ultimately diagnosed with pulmonary tuberculosis.
Positive and negative predictive values are heavily affected by the prevalence of the disease. A hospital-based study would result in higher positive and negative predictive values compared to an epidemiological, population-based study. 4, 7 In our study, the positive predictive value was 100%, compatible with findings by Araki. 4 In contrast, in his epidemiological study Liz 6 found a positive predictive value of only 28%. The negative predictive value in our study was only 12.5%.
The positive likelihood ratio found in this study was infinite, indicating that a positive 4.5% HS provocation test was found far more frequently in those with astmna than in those without. The negative likelihood ratio of 0.16 indicated that false negatives do occur, albeit at a low rate.
We conclude that the 4.5% hypertonic saline challenge test is a sufficient method for diagnosing asthma in children with CRC. This test can be used as an alternative to the histamine provocation. However, further study with large sample size will be needed for widespread usage of this test.
